Facebook
Twitter
LinkedIn
ForwardMiami Cancer Institute Multispecialty Grand Rounds – Improving Combination Checkpoint Blockade for Patients with Melanoma and other Cancers
Combination checkpoint blockade before surgery produces a high response rate among patients with high-risk stage 3 melanoma, with nearly half having no sign of disease at surgery. After attending this conference, providers will know better how to deliver combination immunotherapy and how the field is moving forward with new targets and new ways of assessing patients.
Target Audience
Oncologists, Radiation Oncologists, Hematology Oncologists, Radiation Therapists, General Surgeons, General Practitioners, Obstetricians and Gynecologists, Oncologists, Radiation Oncologists, Nurses, Patient Navigators and all other interested healthcare professionals.
Learning Objectives
- Implement treatment plans that deliver combination immunotherapy.
- Identify and assess new targets for patients moving forward with immunotherapy.
Michael Postow, M.D.
Associate Attending Physician
Chief, Melanoma Service
Memorial Sloan Kettering Cancer Center
New York, New York
Michael Postow, M.D., indicated that he has received grant/research support from RGenix, Infinity, BMS, Merck, Array BioPharma, Novartis and AstraZeneca. He has also served as a consultant with BMS, Merck, Array BioPharma, Incyte, New Link Genetics and Aduro. He will not include off-label or unapproved product usage in his presentation or discussion.
Non-faculty contributors and others involved in the planning, development, and editing/review of the content have relevant financial relationships to disclose.
Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.
Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity has been approved for 1 credit hour, CE Broker Course #20-680158, by the Florida Boards of Medicine, Osteopathic Medicine and by the Florida Council of Physician Assistants.
This activity has also been approved for 1 credit hour for Nurse Practitioners and Nurses. Baptist Health South Florida CE Broker Provider #50-182.
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 General certificate of attendance
- 1.00 Nurse Practitioners
- 1.00 Florida Board of Nursing
Required Hardware/Software
 | PC/Mac UsersThis site is supported on the most recent stable releases of the following browsers:
| ||||||
 | Mobile UsersThis site is supported on the following mobile devices:
| ||||||
 | Technical SupportIf you are experiencing technical difficulties or have received an error message, please send an email to CME@baptisthealth.net and include a print screen of the error message, your browser name and version, username and URL where the error occurred. You can expect a response within 48 hours. |
